Scioto Biosciences
Business Services · Indiana, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9800 Crosspoint Blvd, Indianapolis, Indi...Website
www.sciotobiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Scioto Biosciences
Scioto Biosciences, Inc. is a preclinical stage biotech company focused on innovative research in microbiome therapeutics. They specialize in developing activated bacterial therapeutics aimed at enhancing healing in the gastrointestinal tract and addressing unmet medical needs related to autism and GI disorders. Their ABT platform leverages the gut-brain axis to optimize the delivery of live bacterial therapeutics. The company targets both children and adults, particularly those diagnosed with autism spectrum disorder.Explore more
Scioto Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scioto Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Scioto Biosciences had a recent Job posting/layoffs
Product Launch: Get notified when Scioto Biosciences launches new products
Scioto Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Scioto Biosciences
Earning: See what the market has to say on Scioto Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Scioto Biosciences has new funding data
Check out if Scioto Biosciences is spiking on competitors!
Check if Scioto Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Scioto Biosciences
Compare insights from companies similar to Scioto Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Scioto Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Scioto Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Scioto Biosciences.
Scioto Biosciences financials insights
Gather financial insights about Scioto Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$1.8M
Scioto Biosciences Tech Stack
A closer look at the technologies used by Scioto Biosciences
Scioto Biosciences News & Media
Scioto Biosciences Announces Publication of Phase 1b Study in Autism
FISHERS, Ind.--(BUSINESS WIRE)-- #autism--Scioto Biosciences Inc., (the “Company” or “Scioto Biosciences”) a clinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced the publication of results from a Phase 1b study of their lead product SB-121 in patients with Autistic Spectrum Disorder (ASD). The publication, Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in particScioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder
FISHERS, Ind.--(BUSINESS WIRE)-- #Autism--Scioto Biosciences announced top-line results of its Phase Ib trial of lead asset, SB-121, in patients diagnosed with autism spectrum disorder.Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
INDIANAPOLIS--(BUSINESS WIRE)--Scioto Biosciences announces first patient dosed in Phase Ib trial in patients diagnosed with Autistic Disorder.Scioto Biosciences Receives Series B Investment from Genome & Company
Scioto Biosciences announces a strategic investment of up to $26.5M from Genome & Company and other investors to join in an upcoming tranche.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scioto Biosciences
Sign Up For FreeTo access detailed company insights
Scioto Biosciences, Inc. is a preclinical stage biotech company focused on innovative research in microbiome therapeutics. They specialize in developing activated bacterial therapeutics aimed at enhancing healing in the gastrointestinal tract and addressing unmet medical needs related to autism and GI disorders. Their ABT platform leverages the gut... Read More
